No profile data available.
Fresenius Medical Care AG (FMS) is a healthcare company in the focused walk-in medical services industry, based in Bad Homburg, Germany, with about 107,226 full-time employees.
It reported revenue of 19.63 billion EUR for fiscal year 2025, up 1.5% from fiscal year 2024, and net income of 978.37 million EUR. Its largest business segment, Care Delivery, brought in 64% of segment revenue in fiscal year 2025; United States was the largest region with 72%. Its market capitalization was $11.21 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally.
Fresenius Medical Care reported 19.63 billion EUR in revenue for fiscal year 2025, up 1.5% from 19.34 billion EUR in fiscal year 2024.
Care Delivery, with $13.74 billion or 64% of segment revenue in fiscal year 2025. Next: Care Enablement (26%) and Value-Based Care (10%).
United States: 72% of revenue by region in fiscal year 2025, followed by Rest of the World (25%).
$11.21 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (focused walk-in medical services) include DaVita Inc. (DVA), American Oncology Network, Inc. (AONC), The Oncology Institute, Inc. (TOI), The Joint Corp. (JYNT).